Glatiramer acetate vs placebo
Patients who progressed ‐ at 2 years · people with multiple sclerosis
Glatiramer acetate showed no clear difference in patients who progressed ‐ at 2 years compared with placebo; GRADE not reported.
1 finding from 1 review
- RR 0.75 [0.51, 1.12]2 studies · 299 participantsGRADE not reported